Skip to content

Research exploring the effectiveness of the Infinity-Force

Research exploring the effectiveness of the Infinity-Force - Research exploring the effectiveness of the Infinity-Force

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050832
Enrollment
2
Registered
2023-04-13
Start date
2023-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Day 1 Ingest the test food and exercise Day 2 Exercise only Day 3 Ingest only the test food

Sponsors

Courage Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Males and Females aged 50 to 79 at the time of consent to participate in the study [2]Individuals whose written informed consent has been obtained [3]Individuals who can come to the designated examination date and receive the examination [4]Individuals judged appropriate for the study by the principal

Exclusion criteria

Exclusion criteria: [1]Individuals using medical products [2]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [3]Individuals with history of gastrointestinal disorders except for appendicitis [4]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [5]Individuals who have experienced mood disorder or condition deterioration due to blood sampling in the past [6]Individuals with serious anemia [7]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [8]Individuals whose life style will change during the test period (ex. travel for a long time) [9]Individuals who participated in other clinical studies in the past three months [10]Individuals judged inappropriate for the study by the principal

Design outcomes

Primary

MeasureTime frame
NMN,NAD,NAM,GH,noradrenaline,dopamine,L-dopa,adiponectin,Insulin

Countries

Japan

Contacts

Public ContactKazutoshi Shinoda

Courage Co.,Ltd. CEO

shinoda@courage-beaute.com03-6661-0436

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026